Samantha Semenkow
Stock Analyst at Citigroup
(1.26)
# 3,644
Out of 5,056 analysts
56
Total ratings
37.78%
Success rate
-11.05%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Samantha Semenkow
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PRME Prime Medicine | Maintains: Neutral | $5 → $4.25 | $3.64 | +16.76% | 5 | Nov 11, 2025 | |
| ROIV Roivant Sciences | Maintains: Buy | $25 → $26 | $21.23 | +22.47% | 3 | Nov 11, 2025 | |
| CPRX Catalyst Pharmaceuticals | Maintains: Buy | $31 → $33 | $22.83 | +44.55% | 3 | Nov 7, 2025 | |
| BIOA BioAge Labs | Maintains: Buy | $10 → $15 | $8.02 | +87.03% | 5 | Oct 29, 2025 | |
| MLTX MoonLake Immunotherapeutics | Downgrades: Sell | $5 | $12.66 | -60.51% | 3 | Oct 29, 2025 | |
| BHVN Biohaven | Initiates: Buy | $28 | $8.09 | +246.11% | 1 | Sep 17, 2025 | |
| CABA Cabaletta Bio | Maintains: Buy | $13 → $10 | $2.48 | +303.23% | 4 | Aug 14, 2025 | |
| WVE Wave Life Sciences | Initiates: Buy | $16 | $7.05 | +127.11% | 1 | Jul 16, 2025 | |
| ALLO Allogene Therapeutics | Maintains: Buy | $8 → $4 | $1.23 | +225.20% | 3 | May 15, 2025 | |
| ARGX argenx SE | Maintains: Buy | $796 → $803 | $900.39 | -10.82% | 6 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $60 | $35.50 | +69.01% | 1 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $12 | $4.25 | +182.35% | 1 | Dec 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8 → $15 | $4.17 | +259.71% | 2 | Aug 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Buy | $80 | $10.07 | +694.83% | 2 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $14 | $3.37 | +315.43% | 6 | May 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $16 → $15 | $2.73 | +450.46% | 4 | May 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $33 → $50 | $22.96 | +117.77% | 3 | Sep 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $60 → $56 | $22.23 | +151.91% | 3 | Aug 9, 2023 |
Prime Medicine
Nov 11, 2025
Maintains: Neutral
Price Target: $5 → $4.25
Current: $3.64
Upside: +16.76%
Roivant Sciences
Nov 11, 2025
Maintains: Buy
Price Target: $25 → $26
Current: $21.23
Upside: +22.47%
Catalyst Pharmaceuticals
Nov 7, 2025
Maintains: Buy
Price Target: $31 → $33
Current: $22.83
Upside: +44.55%
BioAge Labs
Oct 29, 2025
Maintains: Buy
Price Target: $10 → $15
Current: $8.02
Upside: +87.03%
MoonLake Immunotherapeutics
Oct 29, 2025
Downgrades: Sell
Price Target: $5
Current: $12.66
Upside: -60.51%
Biohaven
Sep 17, 2025
Initiates: Buy
Price Target: $28
Current: $8.09
Upside: +246.11%
Cabaletta Bio
Aug 14, 2025
Maintains: Buy
Price Target: $13 → $10
Current: $2.48
Upside: +303.23%
Wave Life Sciences
Jul 16, 2025
Initiates: Buy
Price Target: $16
Current: $7.05
Upside: +127.11%
Allogene Therapeutics
May 15, 2025
Maintains: Buy
Price Target: $8 → $4
Current: $1.23
Upside: +225.20%
argenx SE
May 9, 2025
Maintains: Buy
Price Target: $796 → $803
Current: $900.39
Upside: -10.82%
May 2, 2025
Initiates: Buy
Price Target: $60
Current: $35.50
Upside: +69.01%
Dec 2, 2024
Initiates: Buy
Price Target: $12
Current: $4.25
Upside: +182.35%
Aug 9, 2024
Maintains: Buy
Price Target: $8 → $15
Current: $4.17
Upside: +259.71%
Jun 3, 2024
Reinstates: Buy
Price Target: $80
Current: $10.07
Upside: +694.83%
May 22, 2024
Maintains: Buy
Price Target: $10 → $14
Current: $3.37
Upside: +315.43%
May 9, 2024
Maintains: Buy
Price Target: $16 → $15
Current: $2.73
Upside: +450.46%
Sep 27, 2023
Maintains: Buy
Price Target: $33 → $50
Current: $22.96
Upside: +117.77%
Aug 9, 2023
Maintains: Buy
Price Target: $60 → $56
Current: $22.23
Upside: +151.91%